{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:00:18Z","timestamp":1788886818334,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100031495","name":"YOKOYAMA Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21J11426"],"award-info":[{"award-number":["JP21J11426"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23H03018"],"award-info":[{"award-number":["JP23H03018"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21H03041"],"award-info":[{"award-number":["JP21H03041"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02149-y","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:36:41Z","timestamp":1763404601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sequential omics analysis reveals molecular signatures of malignant transformation in recurrent meningiomas"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9372-8898","authenticated-orcid":false,"given":"Kenta","family":"Ohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-3391","authenticated-orcid":false,"given":"Satoru","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7448-742X","authenticated-orcid":false,"given":"Yu","family":"Teranishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0038-728X","authenticated-orcid":false,"given":"Daisuke","family":"Komura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-4965","authenticated-orcid":false,"given":"Atsushi","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8594-091X","authenticated-orcid":false,"given":"Hiroki","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3064-8858","authenticated-orcid":false,"given":"Shogo","family":"Dofuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-5421","authenticated-orcid":false,"given":"Daiichiro","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7854-1462","authenticated-orcid":false,"given":"Yu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2965-2418","authenticated-orcid":false,"given":"Daisuke","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9440-728X","authenticated-orcid":false,"given":"Hiroto","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2929-7990","authenticated-orcid":false,"given":"Genta","family":"Nagae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7148-778X","authenticated-orcid":false,"given":"Masako","family":"Ikemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1763-8380","authenticated-orcid":false,"given":"Tetsuo","family":"Ushiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6201-8885","authenticated-orcid":false,"given":"Shinichi","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4852-1879","authenticated-orcid":false,"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8025-127X","authenticated-orcid":false,"given":"Masahiro","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5964-575X","authenticated-orcid":false,"given":"Hirofumi","family":"Nakatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3309-2330","authenticated-orcid":false,"given":"Shumpei","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0438-1544","authenticated-orcid":false,"given":"Hiroyuki","family":"Aburatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9756-781X","authenticated-orcid":false,"given":"Nobuhito","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"2149_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/neuonc\/nov316","volume":"18","author":"M Abedalthagafi","year":"2016","unstructured":"Abedalthagafi M, Bi WL, Aizer AA, Merrill PH, Brewster R, Agarwalla PK, Listewnik ML, Dias-Santagata D, Thorner AR, Van Hummelen P et al (2016) Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol 18:649\u2013655. https:\/\/doi.org\/10.1093\/neuonc\/nov316","journal-title":"Neuro Oncol"},{"key":"2149_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","volume":"101","author":"O Al-Mefty","year":"2004","unstructured":"Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M (2004) Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210\u2013218. https:\/\/doi.org\/10.3171\/jns.2004.101.2.0210","journal-title":"J Neurosurg"},{"key":"2149_CR3","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA (2014) Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30:1363\u20131369. https:\/\/doi.org\/10.1093\/bioinformatics\/btu049","journal-title":"Bioinformatics"},{"key":"2149_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.wneu.2018.09.004","volume":"120","author":"SS Baeesa","year":"2018","unstructured":"Baeesa SS, Hussein D, Altalhy A, Bakhaidar MG, Alghamdi FA, Bangash M, Abuzenadah A (2018) Malignant transformation and spine metastasis of an intracranial grade I meningioma. In situ immunofluorescence analysis of cancer stem cells case report and literature review. World Neurosurg 120:274\u2013289. https:\/\/doi.org\/10.1016\/j.wneu.2018.09.004","journal-title":"World Neurosurg"},{"key":"2149_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020251","author":"CJ Barger","year":"2019","unstructured":"Barger CJ, Branick C, Chee L, Karpf AR (2019) Pan-cancer analyses reveal genomic features of FOXM1 overexpression in cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11020251","journal-title":"Cancers (Basel)"},{"key":"2149_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040903","author":"V Barresi","year":"2021","unstructured":"Barresi V, Simbolo M, Fioravanzo A, Piredda ML, Caffo M, Ghimenton C, Pinna G, Longhi M, Nicolato A, Scarpa A (2021) Molecular profiling of 22 primary atypical meningiomas shows the prognostic significance of 18q heterozygous loss and CDKN2A\/B homozygous deletion on recurrence-free survival. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13040903","journal-title":"Cancers (Basel)"},{"key":"2149_CR7","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/neuonc\/noaa303","volume":"23","author":"F Behling","year":"2021","unstructured":"Behling F, Fodi C, Gepfner-Tuma I, Kaltenbach K, Renovanz M, Paulsen F, Skardelly M, Honegger J, Tatagiba M, International Consortium on M et al (2021) H3K27me3 loss indicates an increased risk of recurrence in the T\u00fcbingen meningioma cohort. Neuro Oncol 23:1273\u20131281. https:\/\/doi.org\/10.1093\/neuonc\/noaa303","journal-title":"Neuro Oncol"},{"key":"2149_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-017-0014-7","author":"WL Bi","year":"2017","unstructured":"Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y et al (2017) Genomic landscape of high-grade meningiomas. NPJ Genom Med. https:\/\/doi.org\/10.1038\/s41525-017-0014-7","journal-title":"NPJ Genom Med"},{"key":"2149_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, Ligon KL, Palescandolo E, Van Hummelen P, Ducar MD et al (2013) Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45:285\u2013289. https:\/\/doi.org\/10.1038\/ng.2526","journal-title":"Nat Genet"},{"key":"2149_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnen\/60.6.628","volume":"60","author":"DX Cai","year":"2001","unstructured":"Cai DX, Banerjee R, Scheithauer BW, Lohse CM, Kleinschmidt-Demasters BK, Perry A (2001) Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol 60:628\u2013636. https:\/\/doi.org\/10.1093\/jnen\/60.6.628","journal-title":"J Neuropathol Exp Neurol"},{"key":"2149_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/epi.23470","volume":"8","author":"YA Chen","year":"2013","unstructured":"Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, Gallinger S, Hudson TJ, Weksberg R (2013) Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8:203\u2013209. https:\/\/doi.org\/10.4161\/epi.23470","journal-title":"Epigenetics"},{"key":"2149_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","volume":"54","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA, Seo K, Lucas CG, Casey-Clyde TJ, Vasudevan HN et al (2022) Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54:649\u2013659. https:\/\/doi.org\/10.1038\/s41588-022-01061-8","journal-title":"Nat Genet"},{"key":"2149_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES, Getz G (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31:213\u2013219. https:\/\/doi.org\/10.1038\/nbt.2514","journal-title":"Nat Biotechnol"},{"key":"2149_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, Avsar T, Li J, Murray PB, Henegariu O et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077\u20131080. https:\/\/doi.org\/10.1126\/science.1233009","journal-title":"Science"},{"key":"2149_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ng.3651","volume":"48","author":"VE Clark","year":"2016","unstructured":"Clark VE, Harmanci AS, Bai H, Youngblood MW, Lee TI, Baranoski JF, Ercan-Sencicek AG, Abraham BJ, Weintraub AS, Hnisz D et al (2016) Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet 48:1253\u20131259. https:\/\/doi.org\/10.1038\/ng.3651","journal-title":"Nat Genet"},{"key":"2149_CR16","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-018-31659-0","volume":"8","author":"G Collord","year":"2018","unstructured":"Collord G, Tarpey P, Kurbatova N, Martincorena I, Moran S, Castro M, Nagy T, Bignell G, Maura F, Young MD et al (2018) An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures. Sci Rep 8:13537. https:\/\/doi.org\/10.1038\/s41598-018-31659-0","journal-title":"Sci Rep"},{"key":"2149_CR17","doi-asserted-by":"publisher","first-page":"11220","DOI":"10.1038\/s41598-020-68177-x","volume":"10","author":"MV Corniola","year":"2020","unstructured":"Corniola MV, Lemee JM, Meling TR (2020) Histological transformation in recurrent WHO grade I meningiomas. Sci Rep 10:11220. https:\/\/doi.org\/10.1038\/s41598-020-68177-x","journal-title":"Sci Rep"},{"key":"2149_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","volume":"20","author":"MJ de Hoon","year":"2004","unstructured":"de Hoon MJ, Imoto S, Nolan J, Miyano S (2004) Open source clustering software. Bioinformatics 20:1453\u20131454. https:\/\/doi.org\/10.1093\/bioinformatics\/bth078","journal-title":"Bioinformatics"},{"key":"2149_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635","journal-title":"Bioinformatics"},{"key":"2149_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11060-009-9934-0","volume":"95","author":"A Durand","year":"2009","unstructured":"Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367\u2013375. https:\/\/doi.org\/10.1007\/s11060-009-9934-0","journal-title":"J Neurooncol"},{"key":"2149_CR21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/jnen\/nlaa038","volume":"79","author":"G Gauchotte","year":"2020","unstructured":"Gauchotte G, Peyre M, Pouget C, Cazals-Hatem D, Polivka M, Rech F, Varlet P, Loiseau H, Lacomme S, Mokhtari K et al (2020) Prognostic value of histopathological features and loss of H3K27me3 immunolabeling in anaplastic meningioma: a multicenter retrospective study. J Neuropathol Exp Neurol 79:754\u2013762. https:\/\/doi.org\/10.1093\/jnen\/nlaa038","journal-title":"J Neuropathol Exp Neurol"},{"key":"2149_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","volume":"19","author":"SX Ge","year":"2018","unstructured":"Ge SX, Son EW, Yao R (2018) iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinformatics 19:534. https:\/\/doi.org\/10.1186\/s12859-018-2486-6","journal-title":"BMC Bioinformatics"},{"key":"2149_CR23","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-0891","volume":"16","author":"S Goutagny","year":"2010","unstructured":"Goutagny S, Yang HW, Zucman-Rossi J, Chan J, Dreyfuss JM, Park PJ, Black PM, Giovannini M, Carroll RS, Kalamarides M (2010) Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin Cancer Res 16:4155\u20134164. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0891","journal-title":"Clin Cancer Res"},{"key":"2149_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7","journal-title":"BMC Bioinformatics"},{"key":"2149_CR25","doi-asserted-by":"publisher","first-page":"14433","DOI":"10.1038\/ncomms14433","volume":"8","author":"AS Harmanci","year":"2017","unstructured":"Harmanci AS, Youngblood MW, Clark VE, Coskun S, Henegariu O, Duran D, Erson-Omay EZ, Kaulen LD, Lee TI, Abraham BJ et al (2017) Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nat Commun 8:14433. https:\/\/doi.org\/10.1038\/ncomms14433","journal-title":"Nat Commun"},{"key":"2149_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.1239947","volume":"343","author":"BE Johnson","year":"2014","unstructured":"Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K et al (2014) Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343:189\u2013193. https:\/\/doi.org\/10.1126\/science.1239947","journal-title":"Science"},{"key":"2149_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.humpath.2021.06.005","volume":"115","author":"M Jung","year":"2021","unstructured":"Jung M, Kim SI, Lim KY, Bae J, Park CK, Choi SH, Park SH, Won JK (2021) The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma. Hum Pathol 115:96\u2013103. https:\/\/doi.org\/10.1016\/j.humpath.2021.06.005","journal-title":"Hum Pathol"},{"key":"2149_CR28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00401-018-1844-9","volume":"135","author":"LM Katz","year":"2018","unstructured":"Katz LM, Hielscher T, Liechty B, Silverman J, Zagzag D, Sen R, Wu P, Golfinos JG, Reuss D, Neidert MC et al (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol 135:955\u2013963. https:\/\/doi.org\/10.1007\/s00401-018-1844-9","journal-title":"Acta Neuropathol"},{"key":"2149_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/nan.12571","volume":"46","author":"H Kim","year":"2020","unstructured":"Kim H, Park KJ, Ryu BK, Park DH, Kong DS, Chong K, Chae YS, Chung YG, Park SI, Kang SH (2020) Forkhead box M1 (FOXM1) transcription factor is a key oncogenic driver of aggressive human meningioma progression. Neuropathol Appl Neurobiol 46:125\u2013141. https:\/\/doi.org\/10.1111\/nan.12571","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2149_CR30","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.5808\/GI.2018.16.4.e29","volume":"16","author":"MJ Kim","year":"2018","unstructured":"Kim MJ, Kim SC, Kim YJ (2018) A universal analysis pipeline of hybrid capture-based targeted sequencing data with unique molecular indexes (UMIs). Genomics Inform 16:e29. https:\/\/doi.org\/10.5808\/GI.2018.16.4.e29","journal-title":"Genomics Inform"},{"key":"2149_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s42003-020-0873-9","volume":"3","author":"ES Knudsen","year":"2020","unstructured":"Knudsen ES, Nambiar R, Rosario SR, Smiraglia DJ, Goodrich DW, Witkiewicz AK (2020) Pan-cancer molecular analysis of the RB tumor suppressor pathway. Commun Biol 3:158. https:\/\/doi.org\/10.1038\/s42003-020-0873-9","journal-title":"Commun Biol"},{"key":"2149_CR32","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR (2014) Clinvar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42:D980-985. https:\/\/doi.org\/10.1093\/nar\/gkt1113","journal-title":"Nucleic Acids Res"},{"key":"2149_CR33","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41467-025-60653-0","volume":"16","author":"JY Lee","year":"2025","unstructured":"Lee JY, Lee EJ, Seo BY, Kim J, Song Y, Lee D, Moon N, Koo H, Park CK, Kim MS et al (2025) Single-cell analysis reveals a longitudinal trajectory of meningioma evolution and heterogeneity. Nat Commun 16:5481. https:\/\/doi.org\/10.1038\/s41467-025-60653-0","journal-title":"Nat Commun"},{"key":"2149_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111633","author":"S Lee","year":"2019","unstructured":"Lee S, Karas PJ, Hadley CC, Bayley VJ, Khan AB, Jalali A, Sweeney AD, Klisch TJ, Patel AJ (2019) The Role of Merlin\/NF2 Loss in Meningioma Biology. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11111633","journal-title":"Cancers (Basel)"},{"key":"2149_CR35","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754\u20131760. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324","journal-title":"Bioinformatics"},{"key":"2149_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P (2015) The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst 1:417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004","journal-title":"Cell Syst"},{"key":"2149_CR37","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.18632\/oncotarget.26941","volume":"10","author":"J Loewenstern","year":"2019","unstructured":"Loewenstern J, Rutland J, Gill C, Arib H, Pain M, Umphlett M, Kinoshita Y, McBride R, Donovan M, Sebra R et al (2019) Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas. Oncotarget 10:3506\u20133517. https:\/\/doi.org\/10.18632\/oncotarget.26941","journal-title":"Oncotarget"},{"key":"2149_CR38","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"2149_CR39","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41588-024-01747-1","volume":"56","author":"CG Lucas","year":"2024","unstructured":"Lucas CG, Mirchia K, Seo K, Najem H, Chen WC, Zakimi N, Foster K, Eaton CD, Cady MA, Choudhury A et al (2024) Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution. Nat Genet 56:1121\u20131133. https:\/\/doi.org\/10.1038\/s41588-024-01747-1","journal-title":"Nat Genet"},{"key":"2149_CR40","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3171\/2009.9.JNS09617","volume":"112","author":"SL McGovern","year":"2010","unstructured":"McGovern SL, Aldape KD, Munsell MF, Mahajan A, DeMonte F, Woo SY (2010) A comparison of world health organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas. J Neurosurg 112:925\u2013933. https:\/\/doi.org\/10.3171\/2009.9.JNS09617","journal-title":"J Neurosurg"},{"key":"2149_CR41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/jnnp-2019-322257","volume":"91","author":"C Mirian","year":"2020","unstructured":"Mirian C, Duun-Henriksen AK, Juratli T, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L et al (2020) Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis. J Neurol Neurosurg Psychiatry 91:378\u2013387. https:\/\/doi.org\/10.1136\/jnnp-2019-322257","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2149_CR42","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/neuros\/nyaa226","volume":"87","author":"C Mirian","year":"2020","unstructured":"Mirian C, Skyrman S, Bartek J Jr, Jensen LR, Kihlstrom L, Forander P, Orrego A, Mathiesen T (2020) The ki-67 proliferation index as a marker of time to recurrence in intracranial meningioma. Neurosurgery 87:1289\u20131298. https:\/\/doi.org\/10.1093\/neuros\/nyaa226","journal-title":"Neurosurgery"},{"key":"2149_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3171\/2014.10.JNS14502","volume":"123","author":"J Moliterno","year":"2015","unstructured":"Moliterno J, Cope WP, Vartanian ED, Reiner AS, Kellen R, Ogilvie SQ, Huse JT, Gutin PH (2015) Survival in patients treated for anaplastic meningioma. J Neurosurg 123:23\u201330. https:\/\/doi.org\/10.3171\/2014.10.JNS14502","journal-title":"J Neurosurg"},{"key":"2149_CR44","doi-asserted-by":"publisher","first-page":"vdaa129","DOI":"10.1093\/noajnl\/vdaa129","volume":"2","author":"S Nakasu","year":"2020","unstructured":"Nakasu S, Notsu A, Na K, Nakasu Y (2020) Malignant transformation of WHO grade I meningiomas after surgery or radiosurgery: systematic review and meta-analysis of observational studies. Neuro-Oncol Adv 2:vdaa129. https:\/\/doi.org\/10.1093\/noajnl\/vdaa129","journal-title":"Neuro-Oncol Adv"},{"key":"2149_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","volume":"597","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R, Macklin AM, Khan S, Singh O, Karimi S et al (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597:119\u2013125. https:\/\/doi.org\/10.1038\/s41586-021-03850-3","journal-title":"Nature"},{"key":"2149_CR46","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/neuonc\/noz061","volume":"21","author":"F Nassiri","year":"2019","unstructured":"Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J et al (2019) DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro Oncol 21:901\u2013910. https:\/\/doi.org\/10.1093\/neuonc\/noz061","journal-title":"Neuro Oncol"},{"key":"2149_CR47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/bpa.12174","volume":"25","author":"A Olar","year":"2015","unstructured":"Olar A, Wani KM, Sulman EP, Mansouri A, Zadeh G, Wilson CD, DeMonte F, Fuller GN, Aldape KD (2015) Mitotic index is an independent predictor of recurrence-free survival in meningioma. Brain Pathol 25:266\u2013275. https:\/\/doi.org\/10.1111\/bpa.12174","journal-title":"Brain Pathol"},{"key":"2149_CR48","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) Cbtrus statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018. Neuro Oncol 23:iii1\u2013iii105. https:\/\/doi.org\/10.1093\/neuonc\/noab200","journal-title":"Neuro Oncol"},{"key":"2149_CR49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00401-019-02008-w","volume":"138","author":"N Paramasivam","year":"2019","unstructured":"Paramasivam N, Hubschmann D, Toprak UH, Ishaque N, Neidert M, Schrimpf D, Stichel D, Reuss D, Sievers P, Reinhardt A et al (2019) Mutational patterns and regulatory networks in epigenetic subgroups of meningioma. Acta Neuropathol 138:295\u2013308. https:\/\/doi.org\/10.1007\/s00401-019-02008-w","journal-title":"Acta Neuropathol"},{"key":"2149_CR50","doi-asserted-by":"publisher","first-page":"21715","DOI":"10.1073\/pnas.1912858116","volume":"116","author":"AJ Patel","year":"2019","unstructured":"Patel AJ, Wan YW, Al-Ouran R, Revelli JP, Cardenas MF, Oneissi M, Xi L, Jalali A, Magnotti JF, Muzny DM et al (2019) Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proc Natl Acad Sci U S A 116:21715\u201321726. https:\/\/doi.org\/10.1073\/pnas.1912858116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2149_CR51","doi-asserted-by":"publisher","first-page":"105647","DOI":"10.1016\/j.clineuro.2019.105647","volume":"190","author":"BJA Pereira","year":"2020","unstructured":"Pereira BJA, Santana Junior PA, de Almeida AN, Cavalcante SG, de Melo KCM, de Aguiar PHP, Paiva WDS, Oba-Shinjo SM, Marie SKN (2020) Cyclin E1 expression and malignancy in meningiomas. Clin Neurol Neurosurg 190:105647. https:\/\/doi.org\/10.1016\/j.clineuro.2019.105647","journal-title":"Clin Neurol Neurosurg"},{"key":"2149_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL (2015) Stringtie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol 33:290\u2013295. https:\/\/doi.org\/10.1038\/nbt.3122","journal-title":"Nat Biotechnol"},{"key":"2149_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8935-8-6","author":"TJ Peters","year":"2015","unstructured":"Peters TJ, Buckley MJ, Statham AL, Pidsley R, Samaras K, R VL, Clark SJ, Molloy PL, (2015) De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin. https:\/\/doi.org\/10.1186\/1756-8935-8-6","journal-title":"Epigenetics Chromatin"},{"key":"2149_CR54","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/nox231","volume":"20","author":"M Peyre","year":"2018","unstructured":"Peyre M, Gauchotte G, Giry M, Froehlich S, Pallud J, Graillon T, Bielle F, Cazals-Hatem D, Varlet P, Figarella-Branger D et al (2018) De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors. Neuro Oncol 20:1113\u20131121. https:\/\/doi.org\/10.1093\/neuonc\/nox231","journal-title":"Neuro Oncol"},{"key":"2149_CR55","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"2149_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, Schiff D, Weber DC, Wen PY, Vogelbaum MA (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122:4\u201323. https:\/\/doi.org\/10.3171\/2014.7.JNS131644","journal-title":"J Neurosurg"},{"key":"2149_CR57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jocn.2021.05.060","volume":"91","author":"J Ruzevick","year":"2021","unstructured":"Ruzevick J, Gibson A, Tatman P, Emerson S, Ferreira M Jr. (2021) WHO grade III meningioma: de novo tumors show improved progression free survival as compared to secondary progressive tumors. J Clin Neurosci 91:105\u2013109. https:\/\/doi.org\/10.1016\/j.jocn.2021.05.060","journal-title":"J Clin Neurosci"},{"key":"2149_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv377","author":"F Sahm","year":"2016","unstructured":"Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, Kratz A, Capper D, Schefzyk S, Hielscher T et al (2016) TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv377","journal-title":"J Natl Cancer Inst"},{"key":"2149_CR59","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/s1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682\u2013694. https:\/\/doi.org\/10.1016\/s1470-2045(17)30155-9","journal-title":"Lancet Oncol"},{"key":"2149_CR60","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3171\/2017.6.JNS17120","volume":"129","author":"SI Shakir","year":"2018","unstructured":"Shakir SI, Souhami L, Petrecca K, Mansure JJ, Singh K, Panet-Raymond V, Shenouda G, Al-Odaini AA, Abdulkarim B, Guiot MC (2018) Prognostic factors for progression in atypical meningioma. J Neurosurg 129:1240\u20131248. https:\/\/doi.org\/10.3171\/2017.6.JNS17120","journal-title":"J Neurosurg"},{"key":"2149_CR61","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen R, Seshan VE (2016) FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res 44:e131. https:\/\/doi.org\/10.1093\/nar\/gkw520","journal-title":"Nucleic Acids Res"},{"key":"2149_CR62","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308\u2013311. https:\/\/doi.org\/10.1093\/nar\/29.1.308","journal-title":"Nucleic Acids Res"},{"key":"2149_CR63","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers P, Hielscher T, Schrimpf D, Stichel D, Reuss DE, Berghoff AS, Neidert MC, Wirsching HG, Mawrin C, Ketter R et al (2020) CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol 140:409\u2013413. https:\/\/doi.org\/10.1007\/s00401-020-02188-w","journal-title":"Acta Neuropathol"},{"key":"2149_CR64","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/bioinformatics\/bty902","volume":"35","author":"TC Silva","year":"2019","unstructured":"Silva TC, Coetzee SG, Gull N, Yao L, Hazelett DJ, Noushmehr H, Lin DC, Berman BP (2019) ELMER vol 2: an R\/Bioconductor package to reconstruct gene regulatory networks from DNA methylation and transcriptome profiles. Bioinformatics 35:1974\u20131977. https:\/\/doi.org\/10.1093\/bioinformatics\/bty902","journal-title":"Bioinformatics"},{"key":"2149_CR65","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/neuonc\/noy104","volume":"20","author":"S Spiegl-Kreinecker","year":"2018","unstructured":"Spiegl-Kreinecker S, Lotsch D, Neumayer K, Kastler L, Gojo J, Pirker C, Pichler J, Weis S, Kumar R, Webersinke G et al (2018) TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma. Neuro Oncol 20:1584\u20131593. https:\/\/doi.org\/10.1093\/neuonc\/noy104","journal-title":"Neuro Oncol"},{"key":"2149_CR66","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2149_CR67","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","volume":"22","author":"HN Vasudevan","year":"2018","unstructured":"Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY et al (2018) Comprehensive molecular profiling identifies FOXM1 as a key transcription factor for meningioma proliferation. Cell Rep 22:3672\u20133683. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.013","journal-title":"Cell Rep"},{"key":"2149_CR68","doi-asserted-by":"publisher","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","volume":"94","author":"RG Weber","year":"1997","unstructured":"Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 94:14719\u201314724. https:\/\/doi.org\/10.1073\/pnas.94.26.14719","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2149_CR69","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s40478-020-01040-2","volume":"8","author":"EA Williams","year":"2020","unstructured":"Williams EA, Santagata S, Wakimoto H, Shankar GM, Barker FG 2nd, Sharaf R, Reddy A, Spear P, Alexander BM, Ross JS et al (2020) Distinct genomic subclasses of high-grade\/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathol Commun 8:171. https:\/\/doi.org\/10.1186\/s40478-020-01040-2","journal-title":"Acta Neuropathol Commun"},{"key":"2149_CR70","doi-asserted-by":"publisher","DOI":"10.3171\/2019.8.JNS191266","author":"MW Youngblood","year":"2019","unstructured":"Youngblood MW, Duran D, Montejo JD, Li C, Omay SB, Ozduman K, Sheth AH, Zhao AY, Tyrtova E, Miyagishima DF et al (2019) Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg. https:\/\/doi.org\/10.3171\/2019.8.JNS191266","journal-title":"J Neurosurg"},{"key":"2149_CR71","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/neuonc\/noaa226","volume":"23","author":"MW Youngblood","year":"2021","unstructured":"Youngblood MW, Miyagishima DF, Jin L, Gupte T, Li C, Duran D, Montejo JD, Zhao A, Sheth A, Tyrtova E et al (2021) Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol 23:783\u2013794. https:\/\/doi.org\/10.1093\/neuonc\/noaa226","journal-title":"Neuro Oncol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02149-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02149-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02149-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T07:03:20Z","timestamp":1763449400000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02149-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2149"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02149-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the University of Tokyo (approval number: G10028). It was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments, as well as the ethical guidelines for medical research involving human participants. Written informed consent was obtained from all patients for participation in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}